
FDA extends pregnancy warning for common pain relievers
U.S. health officials are expanding the time period that pregnant women should avoid pain relievers including Advil and AleveBy MATTHEW PERRONE AP Health WriterOctober 15, 2020, 10:03 PM• 2 min readShare to FacebookShare to TwitterEmail this articleWASHINGTON -- Pregnant women should avoid a group of common pain relievers including Advil and Aleve for the last four months of pregnancy, federal health officials said Thursday, expanding the warning from three months.The Food and Drug Administration said the fever-and-pain-reducing drugs can cause a rare but serious complication that can harm the fetus. They can lead to kidney problems in the fetus that can result in low levels of amniotic fluid that fills the womb.The warning applies to a family of anti-inflammatory drugs that includes both ...